National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 6/17/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Wallace Akerley, MD

None

Genentech, Inc.

None

None

None

Hossein Borghaei, DO, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.

None

None

None

Andrew C. Chang, MD

None

None

None

None

None

Richard T. Cheney, MD

None

None

None

None

None

Lucian R. Chirieac, MD

None

None

None

None

None

Thomas A. D'Amico, MD

None

Covidien AG;
Scanlan

None

None

None

Todd L. Demmy, MD

None

None

None

None

None

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Apar Kishor P. Ganti, MD

None

None

None

None

None

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
GlaxoSmithKline

None

None

None

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Leora Horn, MD, MSc, FRCPC

None

None

None

None

None

Miranda Hughes, PhD

None

None

None

None

None

Thierry M. Jahan, MD

None

Poniard Pharmaceuticals

None

None

None

Mohammad Jahanzeb, MD, FACP

None

Genentech, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None

Anne Kessinger, MD

Pharmacyclics;
sanofi-aventis U.S.

None

None

None

None

Ritsuko Komaki, MD

None

None

None

None

None

Feng-Ming (Spring) Kong, MD, PhD

None

None

None

None

None

Mark G. Kris, MD

None

Boehringer Ingelheim GmbH;
Covidien AG;
National Cancer Institute;
Chugai Pharmaceuticals;
Clovis Oncology;
Pfizer Inc.

None

None

None

Lee M. Krug, MD

None

Genentech, Inc.;
Morphotek Inc.

None

None

None

Inga T. Lennes, MD, MPH, MBA

None

None

None

None

None

Billy W. Loo, MD, PhD

None

General Electric;
Varian Medical Systems, Inc.

None

None

None

Renato Martins, MD, MPH

None

Eli Lilly and Company;
Genentech, Inc.

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Janis O'Malley, MD

None

None

None

None

None

Raymond U. Osarogiagbon, MD, FACP

Bristol-Myers Squibb Company;
Eli Lilly and Company

Genentech, Inc.;
Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

None

Gregory A. Otterson, MD

None

Abraxis Bioscience, Inc.;
Genentech, Inc.

None

None

None

Jyoti D. Patel, MD

None

Genentech, Inc.

None

None

None

Mary C. Pinder-Schenck, MD

None

None

None

None

None

Katherine M. Pisters, MD

None

None

None

None

None

Karen Reckamp, MD, MS

None

Amgen Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Response Genetics;
Tragara Pharmaceuticals

None

None

None

Gregory J. Riely, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Chugai;
Tragara

None

None

None

Eric Rohren, MD, PhD

None

None

None

None

None

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

None

Douglas E. Wood, MD

None

None

None

None

None

Stephen C. Yang, MD

None

None

None

None

None